BOSTON, MA—Patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and elevated left atrial pressures appear to derive lasting benefits from a shunt that diverts ...
Picking needles in a haystack: Exploring rare variants of a pan-cancer target in the RET landscape from 229,453 adult cancer patients. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Liposomal irinotecan plus bevacizumab in irinotecan-refractory metastatic colorectal cancer: A multicenter, phase I/II trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
The US Food and Drug Administration’s (FDA’s) approval decision about a new treatment for non–muscle invasive bladder cancer (NMIBC) hinges on whether a single-armed trial can be trusted to adequately ...
Praxis Precision Medicines is converting its EMBRAVE3 study of elsunersen for children suffering from a developmental disease into a single-arm study after meeting with the Food and Drug ...
Creatine monohydrate supplements raised serum creatine values in Alzheimer's disease patients in a pilot trial. Preliminary secondary outcome results showed positive trends on brain total creatine and ...
When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in Sydney have uncovered how getting a booster shot in the same arm as your ...
The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results